We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Manufacturers seeking approval for generic versions of drug-device combination products, such as prefilled syringes and auto-injectors, should strongly consider minimizing the differences between the generic’s user interface and that of the reference product, FDA advised in new draft guidance. Read More